Amoxicillin Trihydrate

Producers Shown on SFDA

Producer:Zhuhai Union Biomedical Co., Ltd. was established on May 18, 2021. Its business scope includes general projects: research and development of technology-based materials; R&D of industrial enzyme preparations; R&D of biochemical product technology; Research and development of fermentation process optimization technology; Medical research and experimental development; R&D and application of cell technology; Research and development of biological feed; Wholesale of cosmetics; Sales of disinfectants (excluding hazardous chemicals); Sales of food additives; Feed raw material sales; Sales of feed additives; Animal husbandry and fishery feed sales; Wholesale of pet food and supplies; Retail of pet food and supplies; Health food (pre packaged) sales; Sales of daily necessities; General merchandise sales; Manufacturing of daily chemical products; Sales of daily chemical products. (Except for the items that need to be approved according to law, the business activities shall be carried out independently according to law with the business license) Approved items: drug production; Drug wholesale; Pharmaceutical entrusted production; Drug import and export; Veterinary drug production; Veterinary drug management; Cosmetic production; Inspection and testing services; Health food production; Disinfectant production (excluding hazardous chemicals); Feed production; Production of feed additives; Production of food additives.

Staff: 95 persons

Registered capital: 100 million

Producer:Sinopharm Wichita Pharmaceutical Co., Ltd. was established on September 30, 2002, and its business scope includes drug production; Pharmaceutical trading; Veterinary drug production; Veterinary drug management; Food production; Food business: production and sales of food additives, agricultural and sideline food, industrial enzyme preparations; Production and sales of beverages; Retail wine, tea, cosmetics; Production and sales of organic chemical raw materials (excluding hazardous chemicals, flammable and explosive drugs) and organic fertilizers; Inorganic salt manufacturing

Staff: 3927 persons

Registered capital: 5939.94 million

Producer:Shijiazhuang Pharmaceutical Holding Group Co., Ltd. was established on March 31, 1998, and its business scope includes investment and holding; Sales of gold jewelry; Sales of chemical drugs, intermediates, biological drugs, pharmaceutical preparations, chemical raw materials (excluding hazardous chemicals and precursor chemicals), health products, pharmaceutical packaging materials, and pilot products; Export business of products and technologies produced by other enterprises invested by Shijiazhuang Pharmaceutical Holding Group Co., Ltd; Import and export of raw and auxiliary materials, mechanical equipment and technologies required by the factory; Medical technology development, research and development of new medical processes, new materials, new technologies and new products; Consulting and transferring pharmaceutical technology; Wholesale and retail of pharmaceutical intermediates and other chemical products. (For projects that need to be approved according to law, business activities can only be carried out after approval by relevant departments.) Shijiazhuang Pharmaceutical Holding Group Co., Ltd. invests in 20 companies.

Staff: 22704 persons

Registered capital: 52.136 million

Producer:Henan Lvyuan Pharmaceutical Co., Ltd. mainly produces amoxicillin, ampicillin, vitamins, glyoxalic acid, phenoxyacetic acid, pyridine hydrobromide and 6-APA series products.

Staff: 100-199 persons

Registered capital: 650 million

Producer:North China Pharmaceutical Group Co., Ltd. is one of the largest pharmaceutical enterprises in China. Its predecessor, North China Pharmaceutical Factory, was a key construction project during the "First Five Year Plan" period of China. It was composed of antibiotic factories, starch factories among 156 key projects aided by the former Soviet Union and pharmaceutical glass factories introduced by the former Democratic Germany. It started construction in June 1953 with a total investment of 75.88 million yuan and was put into production in June 1958. Over the past 50 years since its establishment, Sinopharm has been steadily operating and gradually growing from a factory with a single property right structure to an enterprise group with more than 30 subsidiaries and diversified investment entities. The establishment of North China Pharmaceutical Factory started the history of large-scale production of antibiotics in China and ended the history of dependence on imports of penicillin and streptomycin in China.

Staff: 2780 persons

Registered capital: 1715.73 million

Producer:Shandong Lukang Pharmaceutical Co., Ltd. was established on February 15, 1993. Its business scope includes the processing and manufacturing of chemical raw materials and preparations, chemical raw materials, excipients and intermediates for pharmaceutical production, and veterinary drugs within the licensed scope; Production and sales of feed additives (the term of validity is subject to the license). Manufacturing, processing and sales of pharmaceutical packaging products (excluding printed products) and food additives (natamycin); Manufacturing and installation of pharmaceutical and chemical equipment; Pharmaceutical engineering design; Technology development, consultation and service; Import and export trade (projects that must be approved according to law can only be operated after being approved by relevant departments). Shandong Lukang Pharmaceutical Co., Ltd. invests in 17 companies and has 6 branches

Staff: 3277 persons

Registered capital: 880.22 million

Producer:Ruiyang Pharmaceutical Co., Ltd., founded in 1966, is the first powder injection manufacturer in Shandong Province. The company has 15 production workshops including penicillin powder injection preparation workshop, cephalosporin powder injection preparation workshop, freeze-dried powder injection preparation workshop, penicillin bulk drug workshop, cephalosporin bulk drug workshop, solid preparation workshop, small volume injection workshop and traditional Chinese medicine workshop, all of which have passed the national drug GMP certification. The company has also passed the IS09001, ISO14001 and OHS18001 international quality, environment, occupational health and safety management system certification, laying a solid foundation for the development of the enterprise.

Staff: 3000 persons

Registered capital: 366 million 740 thousand

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978